The FDA has granted Teleflex clearance for new versions of its Arrow GPSCath Balloon Dilatation Catheter that have 80-centimeter lengths and higher burst-pressure ratings. The device, which was acquired by Teleflex through its acquisition of Hotspur Technologies last year, is used to treat patients with peripheral artery disease.

Related Summaries